SCHEMBL173480

SCHEMBL173480

C=CC(O)=CCO.[PoH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL51495 0.97
SCHEMBL16701053 0.73
SCHEMBL12504872 0.71 TSHR (0.30)
SCHEMBL30403459 0.69
SCHEMBL2332708 0.69
SCHEMBL14257739 0.69
SCHEMBL7876033 0.69
SCHEMBL13596686 0.69
SCHEMBL1517902 0.69
SCHEMBL6066079 0.67 TBXAS1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6531432-B2 Contact lens packaging solutions JOHNSON & JOHNSON VISION CARE, INC. 2003-03-11 US claimed
EP-4149893-A1 COMPOSITION AND METHOD FOR THE DEWATERING OF AQUEOUS SUSPENSIONS Solenis Technologies Cayman, L.P. (CH) 2023-03-22 EP disclosed
EP-3935036-A1 VETERINARY COMPOSITIONS AND METHODS OF USE THEREFOR Smith, Colleen (US) 2022-01-12 EP disclosed
WO-2021231360-A1 COMPOSITION AND METHOD FOR THE DEWATERING OF AQUEOUS SUSPENSIONS SOLENIS TECHNOLOGIES, L.P. (US) 2021-11-18 WO disclosed
US-20210347691-A1 COMPOSITION AND METHOD FOR THE DEWATERING OF AQUEOUS SUSPENSIONS SOLENIS TECHNOLOGIES, L.P. (US) 2021-11-11 US disclosed
US-9168251-B2 High dose buprenorphine compositions and use as analgesic Zoetis Belgium S.A (BE) 2015-10-27 US disclosed
US-20140329843-A1 HIGH DOSE BUPRENORPHINE COMPOSITIONS AND USE AS ANALGESIC ZOETIS BELGIUM S.A. (BE) 2014-11-06 US disclosed
EP-2611445-A1 HIGH DOSE BUPRENORPHINE COMPOSITIONS AND USE AS ANALGESIC Abbott Laboratories (US) 2013-07-10 EP disclosed
WO-2012031252-A1 HIGH DOSE BUPRENORPHINE COMPOSITIONS AND USE AS ANALGESIC ABBOTT LABORATORIES (US) 2012-03-08 WO disclosed
EP-2015782-A2 COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION Crosslink Genetics Corporation (US) 2009-01-21 EP disclosed
WO-2000052158-A9 METHODS AND REAGENTS FOR INHIBITING ANGIOGENESIS CELL GENESYS INC (US) 2002-06-20 WO disclosed
EP-1181362-A1 METHODS AND REAGENTS FOR INHIBITING ANGIOGENESIS CELL GENESYS, INC. (US) 2002-02-27 EP disclosed
EP-1157122-A1 ANTI-NEOPLASTIC COMPOSITIONS AND USES THEREOF CELL GENESYS, INC. (US) 2001-11-28 EP disclosed
WO-2000052184-A1 ANTI-NEOPLASTIC COMPOSITIONS AND USES THEREOF CELL GENESYS, INC. (US) 2000-09-08 WO disclosed
WO-2000052158-A1 METHODS AND REAGENTS FOR INHIBITING ANGIOGENESIS CELL GENESYS, INC. (US) 2000-09-08 WO disclosed
WO-1997021441-A1 OPHTHALMIC COMPOSITION COMPRISING POLYOXYETHYLENE-POLYOXYPROPYLENE POLYMERS MDV TECHNOLOGIES, INC. (US) 1997-06-19 WO disclosed
EP-0386199-A4 METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM 1990-11-07 EP disclosed
EP-0386199-A1 METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM. GUPTE PRADEEP (US) 1990-09-12 EP disclosed
WO-1990001953-A1 METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM GUPTE PRADEEP (US) 1990-03-08 WO disclosed
EP-0105721-B1 2-SUBSTITUTED PHENYL-4,5,6,7-TETRAHYDRO-2H-INDAZOLES, AND THEIR PRODUCTION AND USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-11-11 EP disclosed